L. plantarum LC27과 B. longum LC67의 프로바이오틱스 복합물(NVP-1702)
L. plantarum LC27과 B. longum LC67의 프로바이오틱스 복합물(NVP-1702)
MFDS recognition no.
2023-19
Approval route
Notified (고시형) — listed in MFDS public standards
Daily intake (as approved)
1.0–1702.0 CFU/일
Approval holder
주식회사 엔비피헬스케어
Approved wording (Korean original)
알콜성 간 손상으로부터 간 건강에 도움을 줄 수 있음
Precautions (Korean original)
영·유아, 어린이, 임산부 및 수유부는 섭취 시 주의할 것.
the FDA, EFSA or your national authorityRequirements differ by market. Confirm ingredient status and label wording with your own authority before importing.
Approvals described here were issued by the Ministry of Food and Drug Safety (MFDS) of the Republic of Korea and are valid in South Korea only. They are not health claims in your jurisdiction and have not been evaluated by the FDA, EFSA, or any other authority. This page reports regulatory facts and does not recommend any product.